Publication | Open Access
An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.
42
Citations
28
References
2009
Year
Taken together, the data indicate that the antitumor efficacy of SM16 is dependent on an immune-mediated mechanism and that SM16 may represent a safe and effective treatment for metastatic breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1